Skip to main content

Table 3 HLA-B antigen frequency among individuals with ESRD and healthy controls

From: Association between human leucocyte antigen subtypes and risk of end stage renal disease in Taiwanese: a retrospective study

 

Patients N = 141

Control N = 190

   

Antigens

Count

Antigen frequency

Count

Antigen frequency

Odds ratio

95 % confidence interval (95 %CI)

P value

B13

25

17.7 %

34

17.9 %

0.99

0.560–1.748

NS

B18

1

0.7 %

1

0.5 %

1.35

0.083–21.771

NS

B27

12

8.5 %

15

7.9 %

1.09

0.491–2.397

NS

B35

10

7.1 %

10

5.3 %

1.37

0.556–3.397

NS

B37

2

1.4 %

1

0.5 %

2.72

0.244–30.292

NS

B38

11

7.8 %

16

8.4 %

0.92

0.413–2.049

NS

B39

10

7.1 %

8

4.2 %

1.74

0.667–4.520

NS

B44

1

0.7 %

2

1.1 %

0.67

0.060–7.479

NS

B46

28

19.9 %

46

24.2 %

0.78

0.456–1.318

NS

B48

7

5.0 %

5

2.6 %

1.93

0.601–6.221

NS

B51

10

7.1 %

21

11.1 %

0.61

0.278–1.349

NS

B52

2

1.4 %

2

1.1 %

1.35

0.188–9.720

NS

B54

10

7.1 %

15

7.9 %

0.89

0.388–2.046

NS

B55

8

5.7 %

13

6.8 %

0.82

0.330–2.033

NS

B56

5

3.5 %

3

1.6 %

2.29

0.539–9.753

NS

B58

34

24.1 %

37

19.5 %

1.31

0.776–2.226

NS

B60

46

32.6 %

66

34.7 %

0.91

0.573–1.444

NS

B61

16

11.3 %

16

8.4 %

1.39

0.671–2.889

NS

B62

13

9.2 %

18

9.5 %

0.97

0.459–2.053

NS

B67

  

1

0.5 %

0.45

0.018–11.040

NS

B7

  

2

1.1 %

0.27

0.013–5.593

NS

B71

  

2

1.1 %

0.27

0.013–5.593

NS

B75

17

12.1 %

21

11.1 %

1.10

0.556–2.178

NS

B76

2

1.4 %

1

0.5 %

2.72

0.244–30.292

NS

B70

1

0.7 %

0

 

4.07

0.165–100.598

NS

B57

1

0.7 %

0

 

4.07

0.165–100.598

NS

B81

1

0.7 %

0

 

4.07

0.165–100.598

NS

B40

1

0.7 %

0

 

4.07

0.165–100.598

NS

  1. N number, NS not significant